$287 Million is the total value of COMMODORE CAPITAL LP's 29 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CCCC | C4 THERAPEUTICS INC | $18,205,000 | +2.3% | 481,094 | 0.0% | 6.34% | -10.5% | |
KRON | KRONOS BIO INC | $7,157,000 | -18.2% | 298,839 | 0.0% | 2.49% | -28.4% | |
MRSN | MERSANA THERAPEUTICS INC | $5,829,000 | -16.1% | 429,228 | 0.0% | 2.03% | -26.6% | |
PMVP | PMV PHARMACEUTICALS INC | $4,270,000 | +3.9% | 125,000 | 0.0% | 1.49% | -9.2% | |
IVA | INVENTIVA SAads | $3,581,000 | -7.3% | 262,658 | 0.0% | 1.25% | -18.9% | |
SBTX | SILVERBACK THERAPEUTICS INC | $3,001,000 | -29.2% | 97,143 | 0.0% | 1.05% | -38.0% | |
BLSA | BCLS ACQUISITION CORP | $2,633,000 | -0.4% | 250,000 | 0.0% | 0.92% | -12.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-10-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
XENON PHARMACEUTICALS INC | 12 | Q3 2023 | 10.3% |
COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.4% |
VIRIDIAN THERAPEUTICS INC | 11 | Q3 2023 | 8.9% |
CYMABAY THERAPEUTICS INC | 11 | Q2 2023 | 5.4% |
KURA ONCOLOGY INC | 11 | Q3 2023 | 7.1% |
CELLDEX THERAPEUTICS INC NEW | 11 | Q3 2023 | 3.8% |
ACLARIS THERAPEUTICS INC | 10 | Q1 2023 | 10.4% |
CELCUITY INC | 10 | Q3 2023 | 7.3% |
KALVISTA PHARMACEUTICALS INC | 10 | Q2 2023 | 2.2% |
MERUS N V | 9 | Q3 2023 | 12.5% |
View COMMODORE CAPITAL LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Ambrx Biopharma Inc. | April 27, 2023 | 31,181,983 | 8.1% |
BELLUS Health Inc. | March 30, 2023 | 6,579,359 | 5.2% |
IMARA Inc. | February 21, 2023 | 2,840,754 | 10.8% |
Karyopharm Therapeutics Inc. | February 14, 2023 | 1,935,609 | 1.7% |
VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Satsuma Pharmaceuticals, Inc.Sold out | November 16, 2022 | 0 | 0.0% |
GENOCEA BIOSCIENCES, INC. | February 14, 2022 | 3,079,756 | 5.4% |
View COMMODORE CAPITAL LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-04-19 |
SC 13G | 2024-03-21 |
13F-HR/A | 2024-02-14 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View COMMODORE CAPITAL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.